Evidence used
- No CISA KEV confirmation is currently recorded.
- EPSS is 0.13% for the current model date.
BlackTreeCVE IntelligenceOpenClaw · OpenClaw
Official source article: GitHub GHSA-9V8J-9C9G-W66C ↗. Check the applicable product and release in the original source.
Low technical severity with no CISA KEV confirmation; remediate through the normal risk-based patch cycle unless local exposure raises the priority.
These OSV and GitHub advisory ranges apply only to the named package and ecosystem. A listed fixed version is not a universal product patch or proof that an update is installed.
| Ecosystem and package | Affected range | First fixed version | Evidence |
|---|---|---|---|
| npmopenclaw | <= 2026.5.10-beta.2 | 2026.5.12 | GitHub advisory ↗upstream repository advisory · 18 Jun 2026 |
Low technical severity with no CISA KEV confirmation; remediate through the normal risk-based patch cycle unless local exposure raises the priority.
Patch availableOpenClaw before 2026.5.12 contains a bootstrap token replay vulnerability allowing callers with pending token access to reuse tokens with broader requested scopes. Attackers can replay bootstrap tokens before approval to escalate pairing authority beyond intended scope limits.
OpenClaw before 2026.5.12 contains a bootstrap token replay vulnerability allowing callers with pending token access to reuse tokens with broader requested scopes. Attackers can replay bootstrap tokens before approval to escalate pairing authority beyond intended scope limits.
A product incorrectly assigns a privilege to a particular actor, creating an unintended sphere of control for that actor.
An attacker operating through a network path may attempt exploitation when the stated preconditions are met. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
OpenClaw before 2026.5.12 contains a bootstrap token replay vulnerability allowing callers with pending token access to reuse tokens with broader requested scopes. Attackers can replay bootstrap tokens before approval to escalate pairing authority beyond intended scope limits.
A product incorrectly assigns a privilege to a particular actor, creating an unintended sphere of control for that actor.
An attacker operating through a network path may attempt exploitation when the stated preconditions are met. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.
No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.
No exploit-tagged reference or CISA SSVC proof-of-concept state is currently recorded. Research may still exist outside the structured feeds.
CWE-266: Incorrect Privilege Assignment. A product incorrectly assigns a privilege to a particular actor, creating an unintended sphere of control for that actor.
CVSS:4.0/AV:N/AC:H/AT:P/PR:N/UI:P/VC:L/VI:L/VA:N/SC:N/SI:N/SA:NCommon Vulnerability Scoring System 4.0: the compact vector below is decoded into plain language.
Operational remediation based on structured source evidence.
Published 16 Jun 2026 · Last source change 16 Jun 2026, 18:36 UTC · CWE-266 · Incorrect Privilege Assignment
Core structured fields are present and their contributing authorities are shown above.
No material field changes have been recorded since change tracking began. Routine source refreshes and cosmetic edits are intentionally excluded.